Page results
-
UCLH is committed to following a set of principles on how the trust will use routinely collected patient data for research. The principles will enable vital health research to take place, while at the same time protecting and using clinical data as patients would expect.
-
This information is for patients who have attended the emergency department with an undisplaced or minimally displaced fracture (broken bone) at the base of your 5th metatarsal.
-
This information has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the oesophagus (gullet).
-
This page has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the bronchus
-
Find more information on bites, stings and animal related injuries.
-
This information has been developed by the welfare and benefits team based in the Macmillan Support and Information Service. It outlines the most common benefits available.
-
UCLH today marks International Clinical Trials Day, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
Mr Patrick Grover is a neurosurgeon with a particular expertise in the management of tumours of the skull base such as vestibular schwannomas and meningiomas, as well as Cerebral Aneurysms, AVMs and cavernomas.
-
Mr Pat O'Brien has been a consultant at UCLH since 1999 and specialises in caring for women with medical problems in pregnancy and complicated births. His research interests are in the same areas.
